Tan YingMeei, Sangfelt Olle, Spruck Charles
Department of Tumor Cell Biology, Sidney Kimmel Cancer Center, San Diego, CA 92121, USA.
Cancer Lett. 2008 Nov 18;271(1):1-12. doi: 10.1016/j.canlet.2008.04.036. Epub 2008 Jun 9.
Fbxw7/hCdc4 is a member of the F-box family of proteins, which function as interchangeable substrate recognition components of the SCF ubiquitin ligases. SCF(Fbxw7/hCdc4) targets several important oncoproteins including c-Myc, c-Jun, cyclin E1, and Notch, for ubiquitin-dependent proteolysis. Recent studies have shown that FBXW7/hCDC4 is mutated in a variety of human tumor types, suggesting that it is a general tumor suppressor in human cancer. Alteration of Fbxw7/hCdc4 function is linked to defects in differentiation, cellular proliferation, and genetic instability. In this review, we summarize what is known about Fbxw7/hCdc4-mediated degradation in the regulation of cellular proliferation and discuss how alteration of its function contributes to human tumorigenesis.
Fbxw7/hCdc4是F-box蛋白家族的成员,该家族作为SCF泛素连接酶可互换的底物识别成分发挥作用。SCF(Fbxw7/hCdc4)靶向包括c-Myc、c-Jun、细胞周期蛋白E1和Notch在内的几种重要的癌蛋白,进行泛素依赖性蛋白水解。最近的研究表明,FBXW7/hCDC4在多种人类肿瘤类型中发生突变,这表明它是人类癌症中的一种普遍的肿瘤抑制因子。Fbxw7/hCdc4功能的改变与分化缺陷、细胞增殖和基因不稳定有关。在这篇综述中,我们总结了关于Fbxw7/hCdc4介导的降解在细胞增殖调控中的已知信息,并讨论了其功能改变如何导致人类肿瘤发生。